Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06722391 · ClinicalTrials.gov registry record · NA

Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism

A NA study of Insulin Resistance, sponsored by University of Texas, El Paso.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06722391 is a NA study of Insulin Resistance that is actively recruiting participants, run by University of Texas, El Paso. The registered enrollment target is 80 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06722391, a NA study of Insulin Resistance, is actively recruiting participants, sponsored by University of Texas, El Paso.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=20 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Control and NMES group will self administer stimulation at home. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.

Conditions Studied

Insulin Resistance

Interventions

  • DEVICE Neuromuscular Electrical Stimulation (Sensory)
  • DEVICE Neuromuscular Electrical Stimulation
  • OTHER Resistance Training

Study Locations (1)

Texas

  • University of Texas at El Paso - El Paso

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-08-19
Est. Completion 2031-09-01
Phase NA

Sponsor

University of Texas, El Paso

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06722391

The ClinicalTrials.gov registry entry for NCT06722391 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (67% lower). The listed sponsor is University of Texas, El Paso, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 3 interventions - of which Neuromuscular Electrical Stimulation (Sensory) is the first listed.

NCT06722391 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06722391 about?

NCT06722391 is a clinical study titled "Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism". Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. I...

What is the current status of trial NCT06722391?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-08-19. Estimated completion is 2031-09-01.

What conditions does trial NCT06722391 study?

This clinical trial studies the following conditions: Insulin Resistance.

What interventions are being tested in trial NCT06722391?

The interventions under investigation include: Neuromuscular Electrical Stimulation (Sensory) (DEVICE), Neuromuscular Electrical Stimulation (DEVICE), Resistance Training (OTHER).

Who is sponsoring clinical trial NCT06722391?

This trial is sponsored by University of Texas, El Paso, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06722391 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Insulin Resistance

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.